SEC Filings

Form 8-K
SELECTA BIOSCIENCES INC filed this Form 8-K on 08/11/2017
Document Outline
Entire Document (277.7 KB)
Subdocument 1 - 8-K - 8-K
Page 1 - UNITED STATES
Page 2 - Item 1.01. Entry into a Material Definitive Agreement.
Page 3 - SIGNATURES
Page 4 - EXHIBIT INDEX
Subdocument 2 - EX-1.1 - EX-1.1
Page 1 - Exhibit 1.1
Page 2 - Company
Page 3 - Maximum Program Amount
Page 4 - Selling Period
Page 5 - Prospectus
Page 6 - Section 6
Page 7 - Exchange Act Compliance
Page 8 - Authorization of the Shares
Page 9 - Material Adverse Effect
Page 10 - FINRA
Page 11 - Regulatory Compliance
Page 12 - Stock Plan
Page 13 - Investment Company Act
Page 14 - USPTO
Page 15 - Environmental Laws
Page 16 - Internal Controls
Page 17 - Sanctions
Page 18 - HIPAA
Page 19 - Stock Exchange Listing
Page 20 - Section 3.
Page 21 - Time of Sale
Page 22 - Fees
Page 23 - Interim Prospectus Supplement )
Page 24 - Agent s Review of Proposed Amendments and Supplements
Page 25 - Filing of Agent Free Writing Prospectuses
Page 26 - Earnings Statement
Page 27 - Triggering Event Date
Page 28 - provided, however
Page 29 - Rule 102
Page 30 - Section 4(m)
Page 31 - No Misstatement or Material Omission
Page 32 - Indemnification of the Company, its Directors and Officers
Page 33 - Section 6
Page 34 - provided, however
Page 35 - Section 7.
Page 36 - Research Analyst Independence
Page 37 - Section 8(d)
Page 38 - [Signature Page Immediately Follows]
Page 39 - N/A
Page 40 - EXHIBIT A
Back to Top